Article
Deep generative design of neutralizing nanobodies against SARS-CoV-2 variants
2024-10-30
Abstract excerpt
In recent years, single-domain heavy chain antibodies (nanobodies), with only one-tenth the molecular weight of conventional antibodies, have emerged as important therapeutic proteins in the fight against SARS-CoV-2. However, the rapid mutation of the virus often renders existing nanobodies ineffective, underscoring the need to develop nanobodies that specifically target new variants. Traditional methods for disco...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 68876211-83f0-508a-9638-d5295ca89c37
- DOI
- 10.1101/2024.10.29.620982
